Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Drug Resistance - Calixa Therapeutics to Make Multiple Presentations on CXA-101 and CXA-101/tazobactam at the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Schering-Plough Corporation - Schering-Plough Reports Long-Term Vicriviroc Data From Phase II Open-Label Extension Study in Treatment-Experienced HIV-Infected Patients
Breast Cancer - Study findings on breast cancer are outlined in reports from Ohio State University
Cancer - Research on cancer described by scientists at University of Texas
Clinical Trial Research - Findings from M. Leblanc and co-researchers advance knowledge in clinical trial research
Drug Development - Reports outline drug development study findings from AstraZeneca
Graft-Versus-Host Disease - Studies from D. Adkins et al add new findings in the area of graft-versus-host disease
Macular Degeneration - Studies conducted at University of Arkansas on macular degeneration recently published
Monoclonal Antibodies - Studies from I.J. Suner and co-researchers in the area of monoclonal antibodies published
Multiple Sclerosis - Reports outline multiple sclerosis study results from M.D. Martin et al
Myelodysplastic Syndrome - Findings from Catholic University broaden understanding of myelodysplastic syndrome
Necrosis - New necrosis study results reported from University of California, Medical Department
Pancreatic Cancer - Reports from Yale University highlight recent research in pancreatic cancer
Prostate Cancer - New findings in prostate cancer described by M.G.E.H. Lam and co-researchers
Solid Cancer - Recent findings from D.S. Boss and co-authors highlight research in solid cancer
Breast Cancer Therapy - Research results from Albert-Ludwigs University, Tumor Biology Center update knowledge of breast cancer therapy
Hepatitis C Virus Therapy - Research on hepatitis C virus therapy described by scientists at Bar-Ilan University, Faculty of Life Sciences
Pharmacokinetics - Data on pharmacokinetics detailed by S. Abe and co-authors
Phototherapy - Researchers at University Hospital, Department of Dermatology release new data on phototherapy
Psoriatic Arthritis - New psoriatic arthritis study findings recently were published by Z. Xu and co-researchers
Achaogen - Achaogen Announces ACHN-490 Clinical Data at the 49th Annual ICAAC Meeting
Acorda Therapeutics - Acorda Therapeutics Announces Data on Retention Rates and Safety from Two Phase 3 Fampridine-SR Extension Studies
Adverse Drug Reactions - Transave Announces Positive Phase II Results for Once-Daily ARIKACE(TM) in the Treatment of Non-CF Bronchiectasis Patients Who Have Pseudomonas Lung Infections
Aeolus Pharmaceuticals, Inc. - Aeolus Pharmaceuticals Initiates Second Study of AEOL 10150 as a Countermeasure to Radiation Exposure in Mice
Alexza Pharmaceuticals, Inc. - Alexza Announces Preliminary Results from its AZ-104 Staccato Loxapine Phase 2b Trial in Patients with Migraine Headache
Antisense Pharma GmbH - FDA and EMEA Grant Orphan Drug Designation for Antisense Pharma's Investigational Drug Trabedersen in Pancreatic Carcinoma
Aradigm Corporation - Aradigm Presents Data Demonstrating Significant Antibacterial Concentrations and Effects in Non-Cystic Fibrosis Bronchiectasis Patients Following Administration of its Once-Daily Inhaled Liposomal Ciprofloxacin
ARIAD Pharmaceuticals, Inc. - ARIAD Announces Result of First Interim Analysis of Phase 3 Succeed Trial of Oral Ridaforolimus, Its Investigational mTOR Inhibitor, in Metastatic Sarcomas
AVEO Pharmaceuticals, Inc. - AVEO Pharmaceuticals Appoints William J. Slichenmyer, M.D., Sc.M., as Chief Medical Officer and Robert C. Young, M.D., to Board of Directors
Cancer - Amgen to Present Pivotal Data From Four Phase 3 Studies at the ECCO 15 - ESMO 34 Congress
Celldex Therapeutics, Inc. - Celldex Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Trial of its CDX-1401 Cancer Vaccine Candidate
Celsion Corporation - Celsion's ThermoDox(R) Study for RCW Breast Cancer Aired on ABC and CBS Affiliate Stations
Clinical Trial Research - Savient Provides Update on Meeting with U.S. Food and Drug Administration for KRYSTEXXA(TM)
Concert Pharmaceuticals, Inc. - Concert Pharmaceuticals Presents Clinical Results Demonstrating Reduced Drug-Drug Interactions with a Deuterium-Modified Compound
CPEX Pharmaceuticals, Inc. - CPEX Pharmaceuticals to Present at Ninth Annual Diabetes Technology Meeting
Cystic Fibrosis - Mpex Reports Positive Phase II Results with Aeroquin, Delivered by PARI Pharma's eFlow Technology
CytRx Corporation - CytRx and Cephalon Oncology Therapies to be Evaluated as Treatment for Relapsed Acute Promyelocytic Leukemia
Diarrhea - Data From Optimer's Second Phase 3 Study of Prulifloxacin Presented at Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)
Drug Resistance - Optimer Announces Presentation of Additional Data From Fidaxomicin Phase 3 Study for the Treatment of Clostridium Difficile Infection (CDI)
Drug Resistance - Trius' Torezolid Antibiotic for the Treatment of Severe Skin Infections Featured at ICAAC Meeting
Fibrosis - InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
GenSpera, Inc. - GenSpera Receives FDA Approval for G-202 Phase I Cancer Trial
Genzyme Corporation - Genzyme's Alemtuzumab for Multiple Sclerosis Shows Durable Treatment Benefit in Review of Four-Year Phase 2 Trial Data
Heart Failure - Nile Therapeutics Announces Poster Presentation at 2009 Heart Failure Society of America Annual Meeting
Heart Failure - Palatin Technologies, Inc. Announces PL-3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting
Hyperion Therapeutics, Inc. - Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Hepatic Encephalopathy
Immunotherapy - STALLERGENES: Immunotherapy Tablet Containing Recombinant Allergen (rBet v 1) of Birch Pollen: Positive Results for a Phase IIb/III Trial
Ipsen - Ipsen: Encouraging Preliminary New Data Available for the Treatment of Short Stature Children with Low IGF-1 Levels
KemPharm, Inc. - KemPharm, Inc. Expands Prodrug Pipeline with Candidate for Treatment of Pain and Closes Series B Financing
Kenta Biotech - Kenta Biotech Reports Phase IIa Data with Lead Candidate Panobacumab in Hospital-Acquired Pneumonia
Kidney Cancer - Keryx Biopharmaceuticals' Phase 2 Data of KRX-0401 (Perifosine) in the Treatment of Advanced Metastatic Renal Cell Cancer Selected for Oral Presentation at the Eighth International Kidney Cancer Symposium
Lantheus Medical Imaging, Inc. - Lantheus Medical Imaging, Inc. Initiates Phase 1 Study Evaluating Safety and Dosimetry of Novel Heart Failure Imaging Agent
Liver Cancer - Jennerex Completes Over-Subscribed Series C Financing for Aggregate Gross Proceeds of Over $5.5 Million
Macular Degeneration - Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
Merck & Co., Inc. - New, Long-Term Data for Odanacatib, Merck's Investigational Cat K Inhibitor, Showed Positive Results in Treating Osteoporosis
Millennium - Millennium Initiates Phase II Trial of Prostate Cancer Compound
Salix Pharmaceuticals, Ltd. - Salix Pharmaceuticals Announces Statistically Significant Results for Both the Primary and Key Secondary Analyses of Rifaximin in the Treatment of Non-Constipation Irritable Bowel Syndrome in Two Phase 3 Trials Target 1 and Target 2
